This MRFR Market Perspective Examines the Historical Trends and Current Scenario of the “Emphysema Market Research Report – Forecast to 2023” to Deliver a Highly Pertinent Growth Forecast. The Report Includes Key Trends, Drivers And Restraints That Are Likely To Influence The Market Over The Next Five Years.
Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the air trapped in the lungs, leaving no space for oxygen-rich air to enter the lungs. Emphysema and chronic bronchitis are together known as the Chronic Obstructive Pulmonary Disease (COPD). The patients suffering from emphysema also have chronic bronchitis. The major causes of emphysema are exposure to air pollutants, chemical fumes, and dust and smoking. The condition can be diagnosed through various tests such as imaging tests that include chest X-ray and CT scan and the lung function test.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5810
The global emphysema market is mainly driven by the high prevalence of respiratory diseases such as chronic bronchitis, emphysema, and others and a huge demand for treatment including smoking cessation drugs and antibiotics. Additionally, the rising availability of diagnostic services for respiratory illness also fuels the growth of the market.
According to the World Health Organization, COPD affects nearly 210 million people which is attributed to the increasing population in urban areas across the globe and growing number of tobacco smokers.
The global emphysema market is expected to grow at a CAGR of 6.1% during the forecast period.
The global emphysema market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into centrilobular and panlobular emphysema.
On the basis of diagnosis, the market is segmented into imaging test, lung function test, and others. The imaging test is further segmented into chest X-ray and CT scan.
On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy.
On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.
Regional Analysis of the Global Emphysema Market
The American emphysema market is segmented into two regions, namely, North America and South America. North America, being the largest market, is mainly driven by the increasing use of imaging test and lung function test for the diagnosis of the disease and huge population base diagnosed with COPD. Furthermore, the U.S. is the largest market in North America owing to the presence of large number of market players manufacturing medications for emphysema and increasing awareness about risk factors and cases of the disease. The American Lung Association stated that in the U.S., COPD is the fourth leading cause of deaths. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for diagnostic medical devices with progress in the medical device sector. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and the increasing demand for treatment options of respiratory diseases
The European emphysema market exhibits a positive growth with an increasing emphasis on the diagnosis of chronic respiratory conditions such as the COPD and asthma and increasing focus on research and development activities for the treatment of respiratory diseases. Germany and the U.K. are the major contributors to the growth of the market. Additionally, increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.
Asia Pacific is expected to be the fastest growing market whose growth is attributed to a huge demand for lung function test and other diagnostic tests and the increasing focus on early diagnosis and treatment of lung diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among the adults, and addiction to smoking. Additionally, rising environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.
The Middle Eastern and African market for emphysema exhibits a steady rise with an increase in the number of healthcare facilities providing treatment for the chronic condition and the flourishing growth of medical device sector especially the diagnostic devices such as MRI and CT. In the African region, the awareness about COPD is increasing and is fueling the growth of the market.
Key Players in the Global Emphysema Market
Some of the key players in this market are Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
Browse Premium Research Reports @ https://www.marketresearchfuture.com/reports/emphysema-market-5810
LIST OF TABLES
Table 1 Emphysema Industry Synopsis, 2017-2023
Table 2 Global Emphysema Market Estimates And Forecast, 2017-2023, (USD Million)
Table 3 Global Emphysema Market By Region, 2017-2023, (USD Million)
Table 4 Global Emphysema Market By Types, 2017-2023, (USD Million)
Table 5 Global Emphysema Market By Diagnosis, 2017-2023, (USD Million)
Table 6 Global Emphysema Market By Treatment, 2017-2023, (USD Million)
Table 7 Global Emphysema Market By End Users, 2017-2023, (USD Million)
Table 8 North America Emphysema Market By Types, 2017-2023, (USD Million)
Table 9 North America Emphysema Market By Diagnosis, 2017-2023, (USD Million)
Table 10 North America Emphysema Market By Treatment, 2017-2023, (USD Million)
Table 11 North America Emphysema Market By End Users, 2017-2023, (USD Million)
Table 12 US Emphysema Market By Types, 2017-2023, (USD Million)
Table 13 US Emphysema Market By Diagnosis, 2017-2023, (USD Million)
Table 14 US Emphysema Market By Treatment, 2017-2023, (USD Million)
Table 15 US Emphysema Market By End Users, 2017-2023, (USD Million)
Table 16 Canada Emphysema Market By Types, 2017-2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Emphysema Market
Figure 3 Segmentation Market Dynamics For Emphysema Market
Figure 4 Global Emphysema Market Share, By Diagnosis 2016
Figure 5 Global Emphysema Market Share, By Treatment 2016
Figure 6 Global Emphysema Market Share, By End Users, 2016
Figure 7 Global Emphysema Market Share, By Region, 2016
Figure 8 North America Emphysema Market Share, By Country, 2016
Figure 9 Europe Emphysema Market Share, By Country, 2016
Figure 10 Asia Pacific Emphysema Market Share, By Country, 2016
Figure 11 Middle East & Africa Emphysema Market Share, By Country, 2016
Figure 12 Global Emphysema Market: Company Share Analysis, 2016 (%)
Figure 13 Intrexon Corporation: Key Financials
Figure 14 Intrexon Corporation: Segmental Revenue
Figure 16 Intrexon Corporation: Geographical Revenue
Figure 17 Pulmonx Inc.: Key Financials
Figure 18 Pulmonx Inc.: Segmental Revenue
Figure 19 Pulmonx Inc.: Geographical Revenue
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5810
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.